insights_auto
Why is SRPT up 4.06%?
Dive Deeperchevron_right
SRPT:NASDAQ
Sarepta Therapeutics Inc
$18.21
arrow_upward
+4.06%(+0.71) 1D
$18.21
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$17.28
High
$18.28
Low
$17.20
Mkt. cap
1.92B
Avg. vol.
3.05M
Volume
3.52M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$17.28
High
$18.28
Low
$17.20
Mkt. cap
1.92B
Avg. vol.
3.05M
Volume
3.52M
52-wk high
$24.68
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
GuruFocus
·
13 hours ago
SRPT Maintained by RBC Capital -- Price Target Lowered to $17.00
Simply Wall Street
·
22 hours ago
Sarepta Therapeutics (SRPT) ELEVIDYS Data Puts Its Valuation Story Back In Focus
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc